Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation
- PMID: 26201685
- DOI: 10.1007/s00125-015-3692-7
Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation
Abstract
Aims/hypothesis: Lipopolysaccharide (LPS) binding protein (LBP) is a novel 65 kDa adipokine, linked to adipose tissue (AT) inflammation, obesity and insulin resistance, that inhibits adipocyte differentiation. Here, we investigated the molecular mechanisms behind these detrimental effects on adipogenesis through whole-genome transcriptomics and in vitro experiments.
Methods: Permanent and transient knockdown (KD) and co-culture experiments were performed in 3T3-L1 and 3T3-F442A cell lines during adipocyte differentiation. Microarray gene expression was performed using Genechip Affymetrix technology and validated by real-time PCR.
Results: LBP KD of 3T3-L1 cells led to a potentiated adipocyte differentiation with a dose-response relationship; genes involved in mitochondrial biogenesis, fatty acid metabolism and peroxisome proliferator-activated receptor γ (PPAR-γ) action were dramatically upregulated in parallel to increased insulin signalling. Cells with LBP KD became refractory to proinflammatory cytokines and other inflammatory stimuli (LPS and palmitate). This phenotype, mediated through disrupted nuclear factor κB (NFκB) signalling, was reversed by a soluble factor present in a co-culture with native cells and by exogenous LBP. Double-silencing of LBP and toll-like receptor 4 (TLR4) again rendered these cells insensitive to co-culture, LBP and inflammatory factors.
Conclusions/interpretation: In summary, LBP is a proinflammatory soluble adipokine that acts as a brake for adipogenesis, strengthening the negative effects of palmitate and LPS on adipocyte differentiation.
Keywords: Adipogenesis; Inflammation; LPS; Lipopolysaccharide binding protein; Palmitate; TLR4.
Similar articles
-
The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.Int J Obes (Lond). 2016 Jun;40(6):907-11. doi: 10.1038/ijo.2016.32. Epub 2016 Feb 16. Int J Obes (Lond). 2016. PMID: 26880233
-
Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.Diabetologia. 2016 Oct;59(10):2208-18. doi: 10.1007/s00125-016-4028-y. Epub 2016 Jun 25. Diabetologia. 2016. PMID: 27344313
-
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.Diabetologia. 2013 Nov;56(11):2524-37. doi: 10.1007/s00125-013-3015-9. Epub 2013 Aug 21. Diabetologia. 2013. PMID: 23963324
-
Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature.Obesity (Silver Spring). 2017 Feb;25(2):391-400. doi: 10.1002/oby.21711. Epub 2016 Dec 21. Obesity (Silver Spring). 2017. PMID: 28001010
-
Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers.Front Immunol. 2021 Jul 6;12:681810. doi: 10.3389/fimmu.2021.681810. eCollection 2021. Front Immunol. 2021. PMID: 34295331 Free PMC article. Review.
Cited by
-
Local free fatty acids trigger the expression of lipopolysaccharide-binding protein in murine white adipose tissue.Biosci Microbiota Food Health. 2022;41(2):54-65. doi: 10.12938/bmfh.2021-061. Epub 2022 Jan 28. Biosci Microbiota Food Health. 2022. PMID: 35433160 Free PMC article.
-
The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.Int J Obes (Lond). 2016 Jun;40(6):907-11. doi: 10.1038/ijo.2016.32. Epub 2016 Feb 16. Int J Obes (Lond). 2016. PMID: 26880233
-
Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.Diabetologia. 2016 Oct;59(10):2208-18. doi: 10.1007/s00125-016-4028-y. Epub 2016 Jun 25. Diabetologia. 2016. PMID: 27344313
-
Loss of LBP triggers lipid metabolic disorder through H3K27 acetylation-mediated C/EBPβ- SCD activation in non-alcoholic fatty liver disease.Zool Res. 2024 Jan 18;45(1):79-94. doi: 10.24272/j.issn.2095-8137.2023.022. Zool Res. 2024. PMID: 38114435 Free PMC article.
-
IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans.Diabetologia. 2022 Aug;65(8):1398-1411. doi: 10.1007/s00125-022-05711-8. Epub 2022 May 19. Diabetologia. 2022. PMID: 35587276 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous